Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1
نویسندگان
چکیده
منابع مشابه
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.
A 47-year-old woman with relapsing-remitting multiple sclerosis (MS), treated with natalizumab for 14 months, reported dysphagia. Brain MRI demonstrated small fluid-attenuated inversion recovery–hyperintense T1-hypointense unenhancing lesions of the right pons and left medulla initially interpreted as new MS plaques (figure 1), but increased and became confluent over 3 months (figure 2). CSF de...
متن کاملRemission and recovery in schizophrenia: practitioner and patient perspectives.
Schizophrenia remains a complex, dynamic, multi-dimensional, and poorly understood condition. Although the concept of heterogeneity in outcome has conceptually overturned the post Kraepelinian legacy of progressive deterioration, a number of factors appear to contribute to perpetuating a pessimistic attitude toward outcome within the field. These include the limited access people with schizophr...
متن کاملImmunologic strategies for HIV-1 remission and eradication.
Antiretroviral therapy (ART) is able to suppress HIV-1 replication indefinitely in individuals who have access to these medications, are able to tolerate these drugs, and are motivated to take them daily for life. However, ART is not curative. HIV-1 persists indefinitely during ART as quiescent integrated DNA within memory CD4(+) T cells and perhaps other long-lived cellular reservoirs. In this...
متن کاملPractical Strategies for Treating
Introduction Mastitis is the most frequent and costly disease of dairy cattle. Losses due to mastitis occur for both subclinical and clinical disease. Losses caused by clinical mastitis are often apparent and consist of discarded milk, transient reductions in milk yield and premature culling (Fetrow, 2000). Perceived financial losses for clinical mastitis vary widely. In 2002-2003, farmers part...
متن کاملNatalizumab-PML survivors with subsequent MS treatment
Objective: To describe the clinico-radiologic outcome of MS patients with natalizumab-related progressive multifocal leukoencephalopathy (Nz-PML) surviving and receiving diseasemodifying therapy (DMT). Methods: We describe clinical and radiologic evolution of Nz-PML survivors in an observational retrospective multicenter cohort to clarify the effect of different subsequent MS DMT strategies. Tw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology - Neuroimmunology Neuroinflammation
سال: 2020
ISSN: 2332-7812
DOI: 10.1212/nxi.0000000000000929